Tina M. Calderon

3.3k total citations
41 papers, 2.7k citations indexed

About

Tina M. Calderon is a scholar working on Virology, Immunology and Neurology. According to data from OpenAlex, Tina M. Calderon has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 17 papers in Immunology and 14 papers in Neurology. Recurrent topics in Tina M. Calderon's work include HIV Research and Treatment (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Cell Adhesion Molecules Research (7 papers). Tina M. Calderon is often cited by papers focused on HIV Research and Treatment (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Cell Adhesion Molecules Research (7 papers). Tina M. Calderon collaborates with scholars based in United States, France and Israel. Tina M. Calderon's co-authors include Joan W. Berman, Eliseo A. Eugenin, Lillie Lopez, Peter J. Gaskill, Dionna W. Williams, Harris Goldstein, Susan Morgello, Teresa G. D’Aversa, Clarisa M. Buckner and Mike Veenstra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Tina M. Calderon

41 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tina M. Calderon United States 28 1.2k 888 726 670 350 41 2.7k
William R. Tyor United States 37 1.8k 1.5× 1.4k 1.6× 990 1.4× 844 1.3× 546 1.6× 90 4.2k
Sieghart Sopper Germany 32 1.2k 1.0× 393 0.4× 994 1.4× 716 1.1× 440 1.3× 133 3.1k
Walter Royal United States 30 676 0.6× 297 0.3× 384 0.5× 462 0.7× 325 0.9× 75 2.4k
Karen M. Weidenheim United States 25 633 0.5× 556 0.6× 341 0.5× 965 1.4× 319 0.9× 78 2.7k
Debbie D. Watry United States 22 704 0.6× 461 0.5× 361 0.5× 303 0.5× 229 0.7× 26 1.5k
Melina Jones United States 21 1.1k 1.0× 544 0.6× 305 0.4× 677 1.0× 174 0.5× 29 2.4k
Désirée Kunkel Germany 26 656 0.6× 406 0.5× 1.3k 1.8× 509 0.8× 384 1.1× 51 2.7k
Hong Pu United States 27 635 0.5× 566 0.6× 249 0.3× 848 1.3× 171 0.5× 47 2.3k
Homa Adle‐Biassette France 35 473 0.4× 627 0.7× 514 0.7× 1.1k 1.7× 821 2.3× 130 4.1k
Lillie Lopez United States 15 478 0.4× 504 0.6× 376 0.5× 358 0.5× 194 0.6× 16 1.4k

Countries citing papers authored by Tina M. Calderon

Since Specialization
Citations

This map shows the geographic impact of Tina M. Calderon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina M. Calderon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina M. Calderon more than expected).

Fields of papers citing papers by Tina M. Calderon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina M. Calderon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina M. Calderon. The network helps show where Tina M. Calderon may publish in the future.

Co-authorship network of co-authors of Tina M. Calderon

This figure shows the co-authorship network connecting the top 25 collaborators of Tina M. Calderon. A scholar is included among the top collaborators of Tina M. Calderon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina M. Calderon. Tina M. Calderon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calderon, Tina M., et al.. (2021). Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19. Frontiers in Immunology. 12. 665773–665773. 21 indexed citations
2.
Calderon, Tina M., et al.. (2020). HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System. Journal of Neuroimmune Pharmacology. 15(4). 729–742. 28 indexed citations
3.
Calderon, Tina M., Dionna W. Williams, Lillie Lopez, et al.. (2017). Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. Journal of Neuroimmune Pharmacology. 12(2). 353–370. 49 indexed citations
4.
Calderon, Tina M., et al.. (2015). Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis. PLoS ONE. 10(2). e0117450–e0117450. 55 indexed citations
5.
Williams, Dionna W., Mike Veenstra, Peter J. Gaskill, et al.. (2014). Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders. Current HIV Research. 12(2). 85–96. 121 indexed citations
6.
Williams, Dionna W., Tina M. Calderon, Lillie Lopez, et al.. (2013). Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS ONE. 8(7). e69270–e69270. 126 indexed citations
7.
Williams, Dionna W., Eliseo A. Eugenin, Tina M. Calderon, & Joan W. Berman. (2012). Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. Journal of Leukocyte Biology. 91(3). 401–415. 154 indexed citations
8.
9.
Buckner, Clarisa M., et al.. (2006). Neuroimmunity and the Blood–Brain Barrier: Molecular Regulation of Leukocyte Transmigration and Viral Entry into the Nervous System with a Focus on NeuroAIDS. Journal of Neuroimmune Pharmacology. 1(2). 160–181. 70 indexed citations
10.
Tarzami, Sima T., et al.. (2005). MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a Gαi-independent pathway. Biochemical and Biophysical Research Communications. 335(4). 1008–1016. 54 indexed citations
11.
Ma, Harry, et al.. (2003). Mechanisms of Hepatocyte Growth Factor–Mediated Vascular Smooth Muscle Cell Migration. Circulation Research. 93(11). 1066–1073. 37 indexed citations
12.
Beitler, Jonathan J., Takao Ohki, Tina M. Calderon, et al.. (2003). Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula1. Journal of Surgical Research. 115(2). 200–208. 22 indexed citations
13.
Ma, Harry, Tina M. Calderon, John T. Fallon, & Joan W. Berman. (2002). Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis. 164(1). 79–87. 68 indexed citations
14.
Greenstein, Stuart, Tina M. Calderon, T. Schreiber, et al.. (2000). Mycophenolate Mofetil Treatment Reduces Atherosclerosis in the Cholesterol-Fed Rabbit. Journal of Surgical Research. 91(2). 123–129. 29 indexed citations
15.
Schreiber, T., Stuart Greenstein, Tina M. Calderon, et al.. (1998). Effect of Mycophenolate Mofetil on Atherosclerosis in a Rabbit Model: Initial Histologic and Immunohistochemical Analyses. Transplantation Proceedings. 30(4). 961–962. 9 indexed citations
16.
Borque, M.J., et al.. (1997). Study of the secretion of substance P, neurotensin and somatostatin in patients with cholelithiasis.. PubMed. 89(6). 425–34. 2 indexed citations
17.
Calderon, Tina M., et al.. (1992). Interleukin 6 modulates c-sis gene expression in cultured human endothelial cells. Cellular Immunology. 143(1). 118–126. 19 indexed citations
18.
Hurwitz, A. A., et al.. (1992). Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes.. The Journal of Experimental Medicine. 176(6). 1631–1636. 86 indexed citations
19.
Berman, Joan W. & Tina M. Calderon. (1992). The role of endothelial cell adhesion molecules in the development of atherosclerosis. Cardiovascular Pathology. 1(1). 17–28. 19 indexed citations
20.
Calderon, Tina M., Natalie Schneiderman, Josef Michl, & Judith K. Christman. (1989). 5,5′-dimethyloxazolidine-2,4-dione is a strong inducer of differentiation of human promyelocytic leukemia (HL-60) cells. Cell Differentiation and Development. 26(3). 181–190. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William R. Tyor Breakdown of academic impact, for papers by Sieghart Sopper Breakdown of academic impact, for papers by Walter Royal Breakdown of academic impact, for papers by Karen M. Weidenheim Breakdown of academic impact, for papers by Debbie D. Watry Breakdown of academic impact, for papers by Melina Jones Breakdown of academic impact, for papers by Désirée Kunkel Breakdown of academic impact, for papers by Hong Pu Breakdown of academic impact, for papers by Homa Adle‐Biassette Breakdown of academic impact, for papers by Lillie Lopez
Rankless by CCL
2026